Review Article
The Role of [18F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1
Table 2
Characteristics of the FDG-PET/CT studies.
| Authors | Time between oral contrast administration and scan (minutes) | Mean of benign lesions | Mean of malignant lesions | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) | Accuracy (%) | ROC analysis optimal cut-off |
| Ferner et al. [7] | 55–60 | | | n/a | n/a | n/a | n/a | n/a | n/a | Cardona et al. [8] | n/a | 1.0 | 4.1 | 100 | 83 | n/a | n/a | n/a | n/a | Bredella et al. [9] | 45–60 | 1.5 | 8.5 | 95 | 72 | 71 | 95 | 82 | n/a | Ferner et al. [10] | 240 | | | 89 | 95 | n/a | n/a | n/a | n/a | Karabatsou et al. [11] | 60 | 2.6 | 10.4 | n/a | n/a | n/a | n/a | n/a | n/a | Warbey et al. [12] | 90 and 240 | 2 (1.9) | 7 (8.1) | 97 | 87 | n/a | n/a | n/a | 3.1 | Benz et al. [13] | 60 | | | 94 | 91 | n/a | n/a | 93 | 6.1 | Moharir et al. [14] | 45 | n/a | n/a | 100 | 86 | 50 | 100 | n/a | n/a | Tsai et al. [15] | 60 | | | 100/100/89 | 81/94/94 | n/a | n/a | n/a | n/a | Derlin et al. [16] | 60 | | | 100 | 74 | 28 | 100 | 77 | 4.1 | Meany et al. [17] | 60–90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | Salamon et al. [18] | n/a | 2.56 | 8.61 | 100 | 79.8 | 40 | 100 | 82 | 3.5 | Chirindel et al. [19] | 60 and 240 | 2 (2.3) | 6.5 (8.3) | 91 | 84 (81) | 67 (63) | 96 | n/a | 3.2 |
|
|
n/a: not available. Value for delayed imaging. Values as per cut-off of 3/4/5.
|